Login
$AMTX
$1.26 -$0.04 (3.08%) Close

Consolidated Condensed Balance Sheets (Current Period Unaudited)

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Current assets:
Cash and cash equivalents
Accounts receivable
Inventories
Tax Credit Sales receivable
Prepaid expenses
Tax credit sale receivable
Section 45Z Production Tax
Other current assets
Total current assets
Property, plant and equipment, net
Restricted cash
Operating lease right-of-use assets
Other assets
Total assets
Liabilities, Current
Accounts payable
Current portion of long term debt
Short term borrowings
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current
Convertible Series B Preferred Stock Subject to Mandatory Redemption
Accrued property taxes
Current portion of operating lease liability
Other current liabilities
Total current liabilities
Liabilities, Noncurrent
Senior secured notes and revolving notes
EB-5 notes
Other long term debt
Series A preferred units
Convertible Series B Preferred Stock Subject to Mandatory Redemption
Convertible Series A Preferred Stock Subject to Mandatory Redemption
Total series A preferred units
Operating lease liability
Other long term liabilities
Total long-term liabilities
Stockholders' deficit:
Series B convertible preferred stock, $0.001 par value; 7,235 authorized; 0 and 1,270 shares issued and outstanding each period, respectively (aggregate liquidation preference of $0 and $3,810 respectively)
Series B Convertible Preferred Stock
Common stock, $0.001 par value; 140,000 authorized; 72,049 and 66,189 shares issued and outstanding each period, respectively
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders' deficit
Total liabilities and stockholders' deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support